|
|
41
|
|
|
4331G
|
|
|
TASIGNA 150MG CAP (NVS) NILOTANIB (BQ)
|
|
|
NILOTINIB
|
|
|
TASIGNA
|
|
|
112'S
|
|
|
BQ
|
|
|
7611.31
|
|
|
67.9581
|
|
|
150MG
|
|
|
CAP
|
|
|
0
|
|
|
BOX
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
COLLINS LTD
|
|
|
|
|
|
|
|
|
2024-04-01
|
|
|
2026-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
ORAL
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|